H
Helen Doll
Researcher at University of East Anglia
Publications - 12
Citations - 2236
Helen Doll is an academic researcher from University of East Anglia. The author has contributed to research in topics: Telehealth & Randomized controlled trial. The author has an hindex of 11, co-authored 12 publications receiving 2081 citations. Previous affiliations of Helen Doll include University of Oxford.
Papers
More filters
Journal ArticleDOI
Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial
Adam Steventon,Martin Bardsley,John Billings,Jennifer Dixon,Helen Doll,Shashi Hirani,Martin Cartwright,Lorna Rixon,Martin Knapp,Martin Knapp,Catherine Henderson,Anne Rogers,Ray Fitzpatrick,Jane Hendy,Stanton Newman +14 more
TL;DR: Telehealth is associated with lower mortality and emergency admission rates, and differences in emergency admissions were greatest at the beginning of the trial, during which the authors observed a particularly large increase for the control group.
Journal ArticleDOI
Use of risk assessment instruments to predict violence and antisocial behaviour in 73 samples involving 24 827 people: systematic review and meta-analysis
TL;DR: Investigation of risk assessment tools commonly used to assess the risk of violence, sexual, and criminal behaviour found they seem to identify low risk individuals with high levels of accuracy, but their use as sole determinants of detention, sentencing, and release is not supported by the current evidence.
Posted Content
Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial
Catherine Henderson,Martin Knapp,Martin Knapp,José-Luis Fernández,Jennifer Beecham,Shashivadan P. Hirani,Martin Cartwright,Lorna Rixon,Michelle Beynon,Anne Rogers,Peter Bower,Helen Doll,Ray Fitzpatrick,Adam Steventon,Martin Bardsley,Jane Hendy,Stanton Newman +16 more
TL;DR: The QALY gain by patients using telehealth in addition to usual care was similar to that by patients receiving usual care only, and total costs associated with the telehealth intervention were higher, compared with standard support and treatment.
Journal ArticleDOI
Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial
Catherine Henderson,Martin Knapp,Martin Knapp,José-Luis Fernández,Jennifer Beecham,Shashivadan P. Hirani,Martin Cartwright,Lorna Rixon,Michelle Beynon,Anne Rogers,Peter Bower,Helen Doll,Ray Fitzpatrick,Adam Steventon,Martin Bardsley,Jane Hendy,Stanton Newman +16 more
TL;DR: In this paper, the authors examined the costs and cost effectiveness of telehealth in addition to standard support and treatment, compared with standard treatment and support, and concluded that telehealth does not seem to be a cost effective addition to the standard treatment.
Journal ArticleDOI
Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial
Martin Cartwright,Shashivadan P. Hirani,Lorna Rixon,Michelle Beynon,Helen Doll,Peter Bower,Martin Bardsley,Adam Steventon,Martin Knapp,Catherine Henderson,Anne Rogers,Caroline Sanders,Ray Fitzpatrick,James Barlow,Stanton Newman +14 more
TL;DR: Second generation, home based telehealth as implemented in the Whole Systems Demonstrator Evaluation was not effective or efficacious compared with usual care only and did not improve quality of life or psychological outcomes for patients with chronic obstructive pulmonary disease, diabetes, or heart failure over 12 months.